A key provision of the Inflation Reduction Act (IRA) of 2022 directed Medicare to negotiate the prices of certain top-selling ...

Despite billions poured into research, new medicines still typically take a decade or more to develop.

Bristol-Myers Squibb can probably continue to grow for a long time. Its dividend looks to be sustainable at the moment. But ...

The moves will affect more than 300 employees across both companies as both firms look to drive growth in the long term.

Income investors are drawn to Aristocrats because these stocks have consistently increased their dividends for decades.

Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics ...

Final data demonstrate CM24 in combination with nivolumab and Nal-IRI/5FU/LV chemotherapy clear and consistent improvement ...

Lotte Biologics Co. has named a new chief executive officer with expertise in the biopharmaceutical field in a move to ...

The US FDA has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.

A healthy 9-year-old boy presented to our dermatology clinic for evaluation of a 2-year history of a bruise-like indurated plaque on his temple after a head-to-head collision with another child ...

Shares of Purple Biotech ($PPBT) surged more than 45% on Monday morning, reaching their highest levels since early October.